Summary

In this episode, Catherine and Melissa are joined by Eden Rahim, a Portfolio Manager at Next Edge Capital. We explore the dynamic world of biotech investing, the impact of AI on medicine development, and advanced options trading strategies. We discuss recent breakthroughs in Alzheimer's treatment, CRISPR technology, and how to generate yield through options, providing valuable insights for investors and health enthusiasts alike.

Chapters

00:00 Introduction and guest background

01:11 History of biotech industry and cycles

04:36 Biotech market recovery and current outlook

06:07 Factors causing biotech volatility

07:43 What is biotech and how it differs from pharma

09:43 Blockbuster drugs and their impact on biotech

11:51 M&A activity and industry growth

16:06 Recent developments in Alzheimer's treatments

18:16 Ownership and development of Alzheimer's drugs

19:58 Advances in gene editing and CRISPR technology

23:13 AI's role in drug repurposing and discovery

26:13 Risks and rewards in biotech investing

27:09 Key factors in biotech stock selection

38:21 Biotech as an investment opportunity and ETFs

40:03 Interest in CRISPR and gene editing

43:51 Regulatory challenges and future of CRISPR

45:19 Longevity and biotech innovations

48:01 Options trading strategies and yield generation

52:30 Practical options trading insights

54:14 Closing remarks and future discussions

Host descriptions:

Catherine Murray, a business newscaster and former Wall Street professional at Goldman, William Blair and Deutsche bank.

Dr. Melissa Hershberg, a medical practitioner with a specialized interest in preventive health, weight loss and aesthetic medicine.

Disclaimer: for entertainment purposes only, please do your own research, your own homework and consult with a financial advisor for investment discussions. In addition to consulting with your Family Doctor, Physician, GP or other health care providers before making any health and beauty decisions.

If you would like to join our email list, please reach out to contactgettinsavvy@gmail.com and let us know.